Testing for SARS-CoV-2: lessons learned and current use cases

ES Theel, JE Kirby, NR Pollock - Clinical Microbiology Reviews, 2024 - journals.asm.org
The emergence and worldwide dissemination of SARS-CoV-2 required both urgent
development of new diagnostic tests and expansion of diagnostic testing capacity on an …

Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo …

ME Deming, ER Brown, MA McArthur, SJ Schrag… - The Lancet …, 2025 - thelancet.com
Background Although existing COVID-19 vaccines are known to be highly effective against
severe disease and death, data are needed to assess their ability to reduce SARS-CoV-2 …

Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal …

RF Relich, K Van Benten, GS Lei… - Microbiology …, 2024 - journals.asm.org
Despite having high analytical sensitivities and specificities, qualitative SARS-CoV-2 nucleic
acid amplification tests (NAATs) cannot distinguish infectious from non-infectious virus in …